ImportRefusal LogoImportRefusal

AT Tallinskiy pharmaceutical plant

✅ Low Risk

FEI: 3008836346 • Tallinn, Harju • ESTONIA

FEI

FEI Number

3008836346

📍

Location

Tallinn, Harju

🇪🇪

Country

ESTONIA
🏢

Address

Tondi 33, , Tallinn, Harju, Estonia

Low Risk

FDA Import Risk Assessment

20.3
LowModerateHighCritical

This firm has a minimal history of FDA import refusals with low-severity violations.

Statistics

1
Total Refusals
3
Unique Violations
5/15/2012
Latest Refusal
5/15/2012
Earliest Refusal

Score Breakdown

Violation Severity
40.0×40%
Refusal Volume
11.2×30%
Recency
0.0×20%
Frequency
10.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4741×

COSMETLBLG

It appears the label does not bear the common or usual name of the cosmetic.

Refusal History

DateProductViolationsDivision
5/15/2012
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
471CSTIC LBLG
473LABELING
474COSMETLBLG
Division of Northeast Imports (DNEI)

Frequently Asked Questions

What is AT Tallinskiy pharmaceutical plant's FDA import refusal history?

AT Tallinskiy pharmaceutical plant (FEI: 3008836346) has 1 FDA import refusal record(s) in our database, spanning from 5/15/2012 to 5/15/2012.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. AT Tallinskiy pharmaceutical plant's FEI number is 3008836346.

What types of violations has AT Tallinskiy pharmaceutical plant received?

AT Tallinskiy pharmaceutical plant has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about AT Tallinskiy pharmaceutical plant come from?

All FDA import refusal data for AT Tallinskiy pharmaceutical plant is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.